Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR 649-684

Plant Biotechnology Journal

Volumn 7, Issue 2, 2009, Pages 129-145

  Matoba, Nobuyuki ^a   Kajiura, Hiroyuki ^b   Cherni, Irene ^a   Doran, Jeffrey D ^a   Bomsel, Morgane ^c   Fujiyama, Kazuhito ^b   Mor, Tsafrir S ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c INSTITUT COCHIN   (France)

Author keywords

gp41 membrane proximal region; HIV vaccine; N glycosylation; Post translational modification; Transgenic plants

Indexed keywords

CHOLERA TOXIN; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYBRID PROTEIN; SUBUNIT VACCINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; FEMALE; GENETICS; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MOUSE; MUCOSAL IMMUNITY; TOBACCO; TRANSGENIC PLANT;

AIDS VACCINES; ANIMALS; CHOLERA TOXIN; FEMALE; GLYCOSYLATION; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TOBACCO; VACCINES, SUBUNIT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; NICOTIANA BENTHAMIANA;

EID: 58149387540     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/j.1467-7652.2008.00381.x     Document Type: Article

References (78)

1. Alfsen, A. Bomsel, M. (2002) HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 8, 8.
2. Arakawa, T., Chong, D.K., Merritt, J.L. Langridge, W.H. (1997) Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 6, 403 413.
3. Arakawa, T., Yu, J., Chong, D.K., Hough, J., Engen, P.C. Langridge, W.H. (1998) A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. Biotechnol. 16, 934 938.
4. Bardor, M., Bourhis, L.-B., Paccalet, P., Cosette, P., Fitchette, A.-C., Vézina, L., Trépanier, S., Dargis, M., Lemieux, R., Lange, C., Faye, L. Lerouge, P. (2003) Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogeneous and suitable for glyco-engineering into human-compatible structures. Plant Biotechnol. J. 1, 451 462.
5. Bauly, J.M., Sealy, I.M., Macdonald, H., Brearley, J., Droge, S., Hillmer, S., Robinson, D.G., Venis, M.A., Blatt, M.R., Lazarus, C.M. Napier, R.M. (2000) Overexpression of auxin-binding protein enhances the sensitivity of guard cells to auxin. Plant Physiol. 124, 1229 1238.
6. Belec, L., Ghys, P.D., Hocini, H., Nkengasong, J.N., Tranchot-Diallo, J., Diallo, M.O., Ettiegne-Traore, V., Maurice, C., Becquart, P., Matta, M., Si-Mohamed, A., Chomont, N., Coulibaly, I.M., Wiktor, S.Z. Kazatchkine, M.D. (2001) Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. J. Infect. Dis. 184, 1412 1422.
7. Belyakov, I.M. Berzofsky, J.A. (2004) Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity, 20, 247 253.
8. Bendtsen, J.D., Nielsen, H., Von Heijne, G. Brunak, S. (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783 795.
9. Bomsel, M. Alfsen, A. (2003) Entry of viruses through the epithelial barrier: pathogenic trickery. Nat. Rev. Mol. Cell Biol. 4, 57 68.
10. Broliden, K., Hinkula, J., Devito, C., Kiama, P., Kimani, J., Trabbatoni, D., Bwayo, J.J., Clerici, M., Plummer, F. Kaul, R. (2001) Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Immunol. Lett. 79, 29 36.
11. Coordinating Committee of the Global HIV/AIDS Vaccine Enterprise (2005) The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan. PLoS Med. 2 : e25.
12. Cox, K.M., Sterling, J.D., Regan, J.T., Gasdaska, J.R., Frantz, K.K., Peele, C.G., Black, A., Passmore, D., Moldovan-Loomis, C., Srinivasan, M., Cuison, S., Cardarelli, P.M. Dickey, L.F. (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 24, 1591 1597.
13. Daniell, H. (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol. J. 1, 1071 1079.
14. Daniell, H., Lee, S.B., Panchal, T. Wiebe, P.O. (2001) Expression of the native cholera toxin b subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 1001 1009.
15. Devito, C., Broliden, K., Kaul, R., Svensson, L., Johansen, K., Kiama, P., Kimani, J., Lopalco, L., Piconi, S., Bwayo, J.J., Plummer, F., Clerici, M. Hinkula, J. (2000a) Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165, 5170 5176.
16. Devito, C., Hinkula, J., Kaul, R., Lopalco, L., Bwayo, J.J., Plummer, F., Clerici, M. Broliden, K. (2000b) Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS, 14, 1917.
17. Devito, C., Hinkula, J., Kaul, R., Kimani, J., Kiama, P., Lopalco, L., Barass, C., Piconi, S., Trabattoni, D., Bwayo, J.J., Plummer, F., Clerici, M. Broliden, K. (2002) Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J. Acquir. Immune Defic. Syndr. 30, 413 420.
18. East, L. Isacke, C.M. (2002) The mannose receptor family. Biochim. Biophys. Acta, 1572, 364 386.
19. Fauci, A.S., Johnston, M.I., Dieffenbach, C.W., Burton, D.R., Hammer, S.M., Hoxie, J.A., Martin, M., Overbaugh, J., Watkins, D.I., Mahmoud, A. Greene, W.C. (2008) HIV vaccine research: the way forward. Science, 321, 530 532.
20. Fishman, P.H., Moss, J. Osborne, J.C. Jr. (1978) Interaction of choleragen with the oligosaccharide of ganglioside GM1: evidence for multiple oligosaccharide binding sites. Biochemistry (Moscow), 17, 711 716.
21. Fitchette-Laine, A.C., Gomord, V., Chekkafi, A. Faye, L. (1997) Distribution of xylosylation and fucosylation in the plant Golgi apparatus. Plant J. 5, 673 682.
22. Francis, D.P., Heyward, W.L., Popovic, V., Orozco-Cronin, P., Orelind, K., Gee, C., Hirsch, A., Ippolito, T., Luck, A., Longhi, M., Gulati, V., Winslow, N., Gurwith, M., Sinangil, F. Berman, P.W. (2003) Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials. AIDS, 17, 147 156.
23. Fujiyama, K., Misaki, R., Katsura, A., Tanaka, T., Furukawa, A., Omasa, T. Seki, T. (2006) N-linked glycan structures of a mouse monoclonal antibody produced from tobacco BY2 suspension-cultured cells. J. Biosci. Bioeng. 101, 212 218.
24. Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M.R., Appel, R.D. Bairoch, A. (2005) Protein identification and analysis tools on the ExPASy Server. In : The Proteomics Protocols Handbook (Walker, J.M., ed.), pp. 571 607 Totowa, NJ : Humana Press.
25. Geyer, B.C., Fletcher, S.P., Griffin, T.A., Lopker, M.J., Soreq, H. Mor, T.S. (2007) Translational control of recombinant human acetylcholinesterase accumulation in plants. BMC Biotechnol. 7, 27.
26. Hanke, T. (2008) STEP trial and HIV-1 vaccines inducing T-cell responses. Expert Rev. Vaccines, 7, 303 309.
27. Haq, T.A., Mason, H.S., Clements, J.D. Arntzen, C.J. (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science, 268, 714 716.
28. Helenius, A. Aebi, M. (2004) Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73, 1019 1049.
29. Henderson, J., Bauly, J.M., Ashford, D.A., Oliver, S.C., Hawes, C.R., Lazarus, C.M., Venis, M.A. Napier, R.M. (1997) Retention of maize auxin-binding protein in the endoplasmic reticulum: quantifying escape and the role of auxin. Planta, 202, 313 323.
30. Holmgren, J., Lonnroth, I., Mansson, J. Svennerholm, L. (1975) Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc. Natl. Acad. Sci. USA, 72, 2520 2524.
31. Jani, D., Meena, L.S., Rizwan-u., l-Haq, Q.M., Singh, Y., Sharma, A.K. Tyagi, A.K. (2002) Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res. 11, 447 454.
32. Jefferis, R. (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 21, 11 16.
33. Kaul, R., Plummer, F., Clerici, M., Bomsel, M., Lopalco, L. Broliden, K. (2001) Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS, 15, 431 432.
34. Keler, T., Ramakrishna, V. Fanger, M.W. (2004) Mannose receptor-targeted vaccines. Expert Opin. Biol. Ther. 4, 1953 1962.
35. Kim, T.G. Langridge, W.H. (2003) Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato. Plant Cell Rep. 21, 884 890.
36. Ko, K., Tekoah, Y., Rudd, P.M., Harvey, D.J., Dwek, R.A., Spitsin, S., Hanlon, C.A., Rupprecht, C., Dietzschold, B., Golovkin, M. Koprowski, H. (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA, 100, 8013 8018.
37. Kondo, A., Suzuki, J., Kuraya, N., Hase, S., Kato, I. Ikenaka, T. (1990) Improved method for fluorescence labeling of sugar chains with sialic acid residues. Agric. Biol. Chem. 54, 2169 2170.
38. Kornfeld, R. Kornfeld, S. (1985) Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54, 631 664.
39. Kurosky, A., Markel, D.E., Peterson, J.W. Fitch, W.M. (1977) Primary structure of cholera toxin beta-chain: a glycoprotein hormone analog? Science, 195, 299 301.
40. Lai, C.Y. (1977) Determination of the primary structure of cholera toxin B subunit. J. Biol. Chem. 252, 7249 7256.
41. Lam, J.S., Huang, H. Levitz, S.M. (2007) Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS ONE 2 : e1009.
42. Lerouge, P., Cabanes-Macheteau, M., Rayon, C., Fischette-Laine, A.C., Gomord, V. Faye, L. (1998) N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 38, 31 48.
43. Lesieur, C., Cliff, M.J., Carter, R., James, R.F., Clarke, A.R. Hirst, T.R. (2002) A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers. J. Biol. Chem. 277, 16 697 16 704.
44. Liljeqvist, S., Ståhl, S., Andréoni, C., Binz, H., Uhlén, M. Murby, M. (1997) Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J. Immunol. Methods, 210, 125 135.
45. Lockman, H. Kaper, J.B. (1983) Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin. J. Biol. Chem. 258, 13 722 13 726.
46. Magerus-Chatinet, A., Yu, H., Garcia, S., Ducloux, E., Terris, B. Bomsel, M. (2007) Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology, 362, 67 74.
47. Maley, F., Trimble, R.B., Tarentino, A.L. Plummer, T.H. Jr. (1989) Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180, 195 204.
48. Mason, H.S., Warzecha, H., Mor, T. Arntzen, C.J. (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8, 324 329.
49. Matoba, N. Mor, T.S. (2006) Plant-derived subunit vaccines. In : Metabolic Engineering and Molecular Pharming (Jaiwal, P.K., ed.), pp. 143 183. Houston, TX : Studium Press.
50. Matoba, N., Magerus, A., Geyer, B.C., Zhang, Y., Muralidharan, M., Alfsen, A., Arntzen, C.J., Bomsel, M. Mor, T.S. (2004) A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc. Natl. Acad. Sci. USA, 101, 13 584 13 589.
51. Matoba, N., Geyer, B.C., Kilbourne, J., Alfsen, A., Bomsel, M. Mor, T.S. (2006) Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR (649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine, 24, 5047 5055.
52. Matoba, N., Griffin, T.A., Mittman, M., Doran, J.D., Alfsen, A., Montefiori, D.C., Hanson, C.V., Bomsel, M. Mor, T.S. (2008) Transcytosis- blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes. Curr. HIV Res. 6, 218 229.
53. Molinari, M. (2007) N-glycan structure dictates extension of protein folding or onset of disposal. Nat. Chem. Biol. 3, 313 320.
54. Mor, T.S., Hoboken, N.J. Mason, H.S. (2004) Transgenic plants as a source for subunit vaccines. In : Handbook of Plant Biotechnology (Christou, P. Klee, H., eds), pp. 768 780, Hoboken, NJ : John Wiley.
55. Mor, T.S., Sternfeld, M., Soreq, H., Arntzen, C.J. Mason, H.S. (2001) Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnol. Bioeng. 75, 259 266.
56. Neutra, M.R. Kozlowski, P.A. (2006) Mucosal vaccines: the promise and the challenge. Nat. Rev. 6, 148 158.
57. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., Nakanishi, U., Matsumura, A., Uozumi, A., Hiroi, T., Morita, S., Tanaka, K., Takaiwa, F. Kiyono, H. (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. USA, 104, 10 986 10 991.
58. Parker, C.E., Deterding, L.J., Hager-Braun, C., Binley, J.M., Schulke, N., Katinger, H., Moore, J.P. Tomer, K.B. (2001) Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5. J. Virol. 75, 10 906 10 911.
59. Petruccelli, S., Otegui, M.S., Lareu, F., Tran Dinh, O., Fitchette, A.C., Circosta, A., Rumbo, M., Bardor, M., Carcamo, R., Gomord, V. Beachy, R.N. (2006) A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol. J. 4, 511 527.
60. Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J.W. Choopanya, K. (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein HIV-1 vaccine among 120 injection drug users in Bangkok, Thailand. J. Infect. Dis. 194, 1661 1671.
61. Saint-Jore-Dupas, C., Faye, L. Gomord, V. (2007) From planta to pharma with glycosylation in the toolbox. Trends Biotechnol. 25, 317 323.
62. Sekaly, R.P. (2008) The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205, 7 12.
63. Stambach, N.S. Taylor, M.E. (2003) Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology, 13, 401 410.
64. Steinbrook, R. (2007) One step forward, two steps back - will there ever be an AIDS vaccine? N. Engl. J. Med. 357, 2653 2655.
65. Tacket, C.O. (2005) Plant-derived vaccines against diarrheal diseases. Vaccine, 23, 1866 1869.
66. Tekoah, Y., Ko, K., Koprowski, H., Harvey, D.J., Wormald, M.R., Dwek, R.A. Rudd, P.M. (2004) Controlled glycosylation of therapeutic antibodies in plants. Arch. Biochem. Biophys. 426, 266 278.
67. Thanavala, Y., Huang, Z. Mason, H.S. (2006) Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Vaccine, 5, 249 260.
68. Triguero, A., Cabrera, G., Cremata, J.A., Yuen, C.T., Wheeler, J. Ramirez, N.I. (2005) Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans. Plant Biotechnol. J. 3, 449 457.
69. Van Droogenbroeck, B., Cao, J., Stadlmann, J., Altmann, F., Colanesi, S., Hillmer, S., Robinson, D.G., Van Lerberge, E., Terryn, N., Van Montagu, M., Liang, M., Depicker, A. De Jaeger, G. (2007) Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc. Natl. Acad. Sci. USA, 104, 1430 1435.
70. Walker, B.D. Burton, D.R. (2008) Toward an AIDS vaccine. Science, 320, 760 764.
71. Walmsley, A.M., Alvarez, M.L., Jin, Y., Kirk, D.D., Lee, S.M., Pinkhasov, J., Rigano, M.M., Arntzen, C.J. Mason, H.S. (2003) Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep. 21, 1020 1026.
72. Whaley, K.J. Zeitlin, L. (2005) Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health. Vaccine, 23, 1819 1822.
73. Wilkinson, J. Cunningham, A.L. (2006) Mucosal transmission of HIV-1: first stop dendritic cells. Curr. Drug Targets, 7, 1563 1569.
74. Yu, H., Alfsen, A., Tudor, D. Bomsel, M. (2008) The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent. Cell Calcium, 43, 73 82.
75. Yu, J. Langridge, W.H. (2001) A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 19, 548 552.
76. Yuki, Y., Nochi, T. Kiyono, H. (2007) Progress towards an AIDS mucosal vaccine: an overview. Tuberculosis (Edinburgh, Scotland), 87 (Suppl. 1 S35 S44.
77. Zheng, N. Gierasch, L.M. (1996) Signal sequences: the same yet different. Cell, 86, 849 852.
78. Zor, T. Selinger, Z. (1996) Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 236, 302 308.